THD NewsDesk: As reported earlier this week, China has initiated to showcase its homegrown vaccines for the first time. The country is trying to reshape its narrative where the contagion was allegedly borne.
The small vials hold high hopes of people. Those vials were presented on a show in Beijing for a trade fair this week. The Chinese companies ‘Sinovac Biotech’ and ‘Sinopharm’ have produced indigenous COVID 19 vaccine contenders respectively. The makers expect that the medicine will hit the market after phase 3 trials are approved.
“Completed the construction of a vaccine factory,” a Sinovac representative told AFP, his firm abled to produce 300 million doses a year.
On Monday, people’s exhilaration crowded booths at the trade fair. They experienced the potential game-changing vaccines. China was severely criticized for not handling the pandemic appropriately. Through this step, it is trying to remold the outbreak of COVID-19.
State officials and media are featuring the recovery of Wuhan. The central Chinese city is highlighted as a success story for fighting the virus. Wuhan was the city where the fatal pathogen was surfaced. China is lauding progress on domestic vaccines. It is a sign of Chinese leadership and durability while battling the unrivaled health threat. The pandemic has thrashed the global economy.
In May, President Xi Jinping pledged to develop a potential vaccine for “global public good.”
Countries battered economies depend on potential vaccines. The vaccines will be displayed to enter phase 3 trials to get regulatory approval. Every country is trying to stamp out the virus. There are 10 vaccines worldwide to enter the trial. Sinopharm stated that it precludes the immunoglobulins to last between one and three years from its jab. The concluding result is awaited after the trials.
Global Times, a nationalistic tabloid from China reported: “the price of the vaccines will not be high.”
Every two doses would cost below 1,000 yuan ($146). Sinopharm’s Chairman has been injected with one of the candidate vaccines. Xinhua, china’s news agency reported that a new vaccine candidate can fight the mutations in coronavirus. The vaccine candidate was developed by military scientists. Last month, 5.7 billion doses of the vaccines under progress were preordered around the world.
Meanwhile, World health organization has foretold that worldwide immunization against COVID-19 will be possible in the middle of next year.
